(Q38108767)

29 August 2017

title

Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported (English)

1 reference

29 August 2017

0 references

1 reference

Axel Petzold

1

1 reference

29 August 2017

Gordon T Plant

series ordinal

2

1 reference

29 August 2017

publication date

23 May 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

261

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

17-26

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-013-6957-4

29 August 2017

exact match

0 references

cites work

Chronic relapsing inflammatory optic neuropathy (CRION).

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

NMO-IgG predicts the outcome of recurrent optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Treatment of corticosteroid dependent optic neuropathy with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

51-year-old female with steroid-responsive optic neuropathy: a new case of chronic relapsing inflammatory optic neuropathy (CRION).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

The use of infliximab in ocular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Chronic relapsing inflammatory optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Recurrent subacute visual loss presenting in a 52-year-old Caucasian woman with chronic relapsing inflammatory optic neuropathy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Optic neuropathy complicating multifocal choroiditis and panuveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Optic neuritis in an ethnically diverse population: higher risk of atypical cases in patients of African or African-Caribbean heritage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

The origin of pain in optic neuritis. Determinants of pain in 101 eyes with optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

The OSCAR-IB consensus criteria for retinal OCT quality assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Microcystic macular oedema in multiple sclerosis is associated with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Microcystic macular oedema confirmed, but not specific for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Management of acute optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Immune-mediated CNS diseases: a review on nosological classification and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Long-term complications of past glucocorticoid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Cerebral vasoconstriction, headache and sometimes stroke: one syndrome or many?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-6957-4

Chronic relapsing inflammatory optic neuropathy (CRION) without detection of IgG-NMO antibodies

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Ipsilateral uveitis and optic neuritis in multiple sclerosis

1 reference

12 December 2020

Serum GFAP levels in optic neuropathies

1 reference

12 December 2020

The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies.

1 reference

12 December 2020

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS

1 reference

12 December 2020

Eye disorders in patients with multiple sclerosis: natural history and management

1 reference

12 December 2020

Glial but not axonal protein biomarkers as a new supportive diagnostic criteria for Devic neuromyelitis optica? Preliminary results on 188 patients with different neurological diseases

1 reference

12 December 2020

Recurrent optic neuritis: clues from a long-term follow up study of recurrent and bilateral optic neuritis patients.

1 reference

12 December 2020

Hyperacute corticosteroid treatment of optic neuritis at the onset of pain may prevent visual loss: a case series

1 reference

12 December 2020

Microcystic macular oedema in MS: T2 lesion or black hole?

1 reference

12 December 2020

Intravenous immunoglobulin in recurrent-relapsing inflammatory optic neuropathy

1 reference

12 December 2020

Optic neuritis: experience from a south Indian demyelinating disease registry

1 reference

12 December 2020

Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis

1 reference

12 December 2020

10.1007/S00415-013-6957-4

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1015129981

0 references

1 reference